Brain47Brain47Join Brain47
1TZ

INFUSYSTEMS HLDG.DL-0001

Healthcare · EUR · F

1TZ

Price

€8.44

-1.33%

Cap

€169.70M

Earnings

—

30d Trend

-2.1%

1TZ
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityLow

4% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level15
Momentum56
Technical51
Fund Quality46
Cost Efficiency74

Raw weighted: 61×Macro 0.99 (−1%)=60

RISK

15/100
90d Volatility
3.6%Low
ATR %
0.3%Low daily moves
Max Drawdown (1Y)
-1.0%Resilient

MOMENTUM

56/100
6-1M Momentum
+3.3%Flat
1M Return
+0.4%Stable

TECHNICAL

51/100
RSI (14)
55.2Neutral
MACD
-0.13Bearish momentum
Bollinger Band
48%Mid-range
Trend Quality (KER)
0.149Noisy/choppy

FUND QUALITY

46/100
Replication
SyntheticUses swaps (counterparty risk)
Domicile
LuxembourgCheck tax treaty

COST EFFICIENCY

74/100
Expense Ratio
0.20%Low cost
Fund Size (AUM)
$865MSmall
Tracking Difference
-0.03%Excellent tracking

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months34
3-12 months48
1-5+ years ★66

12-24 month value thesis — fundamentally underpriced

BRAIN47'S ASSESSMENT

I rate INFUSYSTEMS HLDG.DL-0001 at 60/100 — a STRONG reading on the Brain47 Signal. The strongest factor is risk management at 85/100. I classify this as a defensive position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

+0.4%

3 MONTHS

+3.0%

12 MONTHS

—

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

12-24 month value thesis — fundamentally underpriced. low-risk profile and Cost Efficiency (74) are the primary strengths. Historical volatility is low at 4%. I classify this as a defensive holding — low volatility and resilient fundamentals provide portfolio ballast.

defensiveScore: 60/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.